The U.S. Department of Health and Human Services is on a bold mission to develop a universal flu vaccine within four years, a project that could revolutionize how we combat influenza and prepare for future pandemics. Funded by $500 million, this initiative aims for FDA approval by 2029, with clinical trials starting soon. Experts weigh in on the challenges and potential of this ambitious project.
Flu activity in the U.S. is declining, yet hospitalizations remain high. The CDC reports nearing 100 pediatric deaths this season. What does this mean for public health?
Discover the alarming truth about the severity of this flu season and the consequences of reduced vaccination campaigns. Insights from a virologist shed light on the potential risks and implications.
